A detailed history of En Rich Financial Partners LLC transactions in Biogen Inc. stock. As of the latest transaction made, En Rich Financial Partners LLC holds 66 shares of BIIB stock, worth $10,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66
Previous 66 -0.0%
Holding current value
$10,421
Previous $15.3 Million 16.39%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$212.02 - $267.71 $13,993 - $17,668
66 New
66 $14.2 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track En Rich Financial Partners LLC Portfolio

Follow En Rich Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of En Rich Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on En Rich Financial Partners LLC with notifications on news.